Repare Therapeutics (RPTX)
(Delayed Data from NSDQ)
$2.91 USD
-0.10 (-3.32%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $2.91 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.82 |
EPS Last Quarter | -0.82 |
Last EPS Surprise | 3.53% |
ABR | 1.25 |
Earnings ESP
|
1.09% |
---|---|
Current Year | -2.31 |
Next Year | -3.28 |
EPS (TTM) | -1.64 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.32M | 4.72M | 61.02M | 21.70M |
# of Estimates | 5 | 5 | 6 | 4 |
High Estimate | 9.10M | 9.10M | 71.68M | 40.00M |
Low Estimate | 1.50M | 1.50M | 53.50M | 8.00M |
Year ago Sales | 2.16M | 13.05M | 51.13M | 61.02M |
Year over Year Growth Est. | 100.00% | -63.83% | 19.34% | -64.44% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.82 | -0.86 | -2.31 | -3.28 |
# of Estimates | 5 | 5 | 6 | 5 |
Most Recent Consensus | -0.82 | -0.84 | -2.15 | -3.33 |
High Estimate | -0.77 | -0.77 | -2.09 | -2.70 |
Low Estimate | -0.87 | -0.96 | -2.92 | -3.72 |
Year ago EPS | -0.45 | -0.67 | -2.23 | -2.31 |
Year over Year Growth Est. | -82.22% | -28.36% | -3.59% | -42.13% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 2 | 2 | 3 | 3 |
Up Last 60 Days | 2 | 2 | 3 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 2 | 1 | 2 |
Down Last 60 Days | 0 | 2 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.82 | -0.86 | -2.31 | -3.28 |
7 Days Ago | -0.83 | -0.88 | -2.33 | -3.35 |
30 Days Ago | -0.85 | -0.85 | -2.35 | -3.21 |
60 Days Ago | -0.85 | -0.85 | -2.35 | -3.21 |
90 Days Ago | -0.86 | -0.86 | -2.42 | -3.29 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.82 | -0.87 | -2.16 | -3.28 |
Zacks Consensus Estimate | -0.82 | -0.86 | -2.31 | -3.28 |
Earnings ESP | 1.09% | -1.40% | 6.47% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.82 | 0.30 | -0.67 | -0.45 | NA |
Estimate | -0.85 | -0.10 | -0.56 | -0.86 | NA |
Difference | 0.03 | 0.40 | -0.11 | 0.41 | 0.18 |
Surprise | 3.53% | 400.00% | -19.64% | 47.67% | 107.89% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more